[Metformin-associated lactic acidosis: incidence, diagnosis, prognostic factors and treatment]. 2012

M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
Departamento de Anestesiología y Cuidados Intensivos, Clínica Universidad de Navarra, Pamplona, España.

We describe the case of a patient with severe lactic acidosis, as well as presenting some data on its incidence, diagnosis, prognostic factors, and the most appropriate treatment. A 76 year-old male patient with diabetes on treatment with metformin, hypertension, dyslipaemia, and with mild cognitive impairment, was admitted to the Intensive Care Unit in a state of circulatory shock, requiring aggressive treatment with vasopressors and volume. The patient had acute kidney injury with an anuria of 3 days, probably secondary to dehydration to vomiting and to NSAIDs. As a result of the acute renal damage, the patient suffered a severe metformin-associated lactic acidosis. The rest of the causes of metabolic acidosis with an increased anion gap were ruled out, as well as a possible sepsis or rhabdomyolysis. Metformin-associated lactic acidosis is an uncommon metabolic condition, but with a high mortality. To reduce the mortality of these patients, it is important to make an early diagnosis using the clinical records, physical examination, and laboratory tests, with an early resuscitation with volume, vasopressors, bicarbonate, and renal replacement therapy.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000140 Acidosis, Lactic Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as DIABETES MELLITUS; LEUKEMIA; or LIVER FAILURE. Lactic Acidosis
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
January 1999, WMJ : official publication of the State Medical Society of Wisconsin,
M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
July 2009, Critical care medicine,
M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
March 2015, Endocrinology and metabolism (Seoul, Korea),
M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
October 2006, Annales francaises d'anesthesie et de reanimation,
M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
November 1990, Ugeskrift for laeger,
M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
September 2009, BMJ (Clinical research ed.),
M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
March 2015, The American journal of the medical sciences,
M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
June 1978, Australian and New Zealand journal of medicine,
M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
July 1996, The American journal of medicine,
M Vives, and J Romano, and E Stoll, and A Lafuente, and D Nagore, and P Monedero
January 2015, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
Copied contents to your clipboard!